Evaluation of a PCR-based lateral flow device for detecting Aspergillus and Candida species from clinical specimens

Objectives: The diagnosis of invasive fungal diseases (IFDs) is time consuming and lacks sensitivity. In this research a rapid and easy to use immunochromatography-based DNA biosensor system was developed to detect Candida and Aspergillus pathogens at genus level, while specifically detecting Candid...

Full description

Bibliographic Details
Published in:Heliyon
Main Author: Khalid A.; Santhanam J.; Tzar M.N.; Chua A.-L.; Abdul Wahid S.F.; Wan Mat W.R.; Rahman R.A.; Periyasamy P.
Format: Article
Language:English
Published: Elsevier Ltd 2025
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85216464445&doi=10.1016%2fj.heliyon.2025.e42245&partnerID=40&md5=af08612f39828d77e759fb59853bec62
id 2-s2.0-85216464445
spelling 2-s2.0-85216464445
Khalid A.; Santhanam J.; Tzar M.N.; Chua A.-L.; Abdul Wahid S.F.; Wan Mat W.R.; Rahman R.A.; Periyasamy P.
Evaluation of a PCR-based lateral flow device for detecting Aspergillus and Candida species from clinical specimens
2025
Heliyon
11
3
10.1016/j.heliyon.2025.e42245
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85216464445&doi=10.1016%2fj.heliyon.2025.e42245&partnerID=40&md5=af08612f39828d77e759fb59853bec62
Objectives: The diagnosis of invasive fungal diseases (IFDs) is time consuming and lacks sensitivity. In this research a rapid and easy to use immunochromatography-based DNA biosensor system was developed to detect Candida and Aspergillus pathogens at genus level, while specifically detecting Candida glabrata, Candida krusei and Aspergillus terreus. This system combines multiplex PCR with a lateral flow assay (LFA) dipstick. Methods: Three separate multiplexed PCR reactions were designed together with a testing algorithm, using biotin, digoxigenin and Tamra fluorophore-labelled fungal internal transcribed spacer universal fungal primers, fungal genera-specific primers, and species-specific primers to produce labelled PCR products that were detected on the LFA dipstick. The LFA dipstick, in a modified sandwich format, utilises immobilised antibodies complementary to the fluorophore labels on the PCR products, and gold nanoparticles to form a visible red line that indicates the presence of the targeted fungus. To validate the developed system, 203 clinical samples suspected of fungal infection were collected from two hospitals in Kuala Lumpur and tested. Results: The limits of detection of the multiplexed PCR were in the range of 5–100 CFU/mL for fungal spiked human blood samples. Against the clinical diagnosis of proven or probable IFDs, the findings show that the LFA system produced a high specificity of 99.4 % while the sensitivity was only moderate at 47.8 % due to the difficulty of extracting fungal DNA from blood samples. The positive and negative predictive values however were promising at 91.7 % and 93.7 %, respectively. Conclusion: The developed LFA system has great potential for further refinement to be used as a new tool in the detection of IFDs. © 2025 The Authors
Elsevier Ltd
24058440
English
Article
All Open Access; Gold Open Access
author Khalid A.; Santhanam J.; Tzar M.N.; Chua A.-L.; Abdul Wahid S.F.; Wan Mat W.R.; Rahman R.A.; Periyasamy P.
spellingShingle Khalid A.; Santhanam J.; Tzar M.N.; Chua A.-L.; Abdul Wahid S.F.; Wan Mat W.R.; Rahman R.A.; Periyasamy P.
Evaluation of a PCR-based lateral flow device for detecting Aspergillus and Candida species from clinical specimens
author_facet Khalid A.; Santhanam J.; Tzar M.N.; Chua A.-L.; Abdul Wahid S.F.; Wan Mat W.R.; Rahman R.A.; Periyasamy P.
author_sort Khalid A.; Santhanam J.; Tzar M.N.; Chua A.-L.; Abdul Wahid S.F.; Wan Mat W.R.; Rahman R.A.; Periyasamy P.
title Evaluation of a PCR-based lateral flow device for detecting Aspergillus and Candida species from clinical specimens
title_short Evaluation of a PCR-based lateral flow device for detecting Aspergillus and Candida species from clinical specimens
title_full Evaluation of a PCR-based lateral flow device for detecting Aspergillus and Candida species from clinical specimens
title_fullStr Evaluation of a PCR-based lateral flow device for detecting Aspergillus and Candida species from clinical specimens
title_full_unstemmed Evaluation of a PCR-based lateral flow device for detecting Aspergillus and Candida species from clinical specimens
title_sort Evaluation of a PCR-based lateral flow device for detecting Aspergillus and Candida species from clinical specimens
publishDate 2025
container_title Heliyon
container_volume 11
container_issue 3
doi_str_mv 10.1016/j.heliyon.2025.e42245
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85216464445&doi=10.1016%2fj.heliyon.2025.e42245&partnerID=40&md5=af08612f39828d77e759fb59853bec62
description Objectives: The diagnosis of invasive fungal diseases (IFDs) is time consuming and lacks sensitivity. In this research a rapid and easy to use immunochromatography-based DNA biosensor system was developed to detect Candida and Aspergillus pathogens at genus level, while specifically detecting Candida glabrata, Candida krusei and Aspergillus terreus. This system combines multiplex PCR with a lateral flow assay (LFA) dipstick. Methods: Three separate multiplexed PCR reactions were designed together with a testing algorithm, using biotin, digoxigenin and Tamra fluorophore-labelled fungal internal transcribed spacer universal fungal primers, fungal genera-specific primers, and species-specific primers to produce labelled PCR products that were detected on the LFA dipstick. The LFA dipstick, in a modified sandwich format, utilises immobilised antibodies complementary to the fluorophore labels on the PCR products, and gold nanoparticles to form a visible red line that indicates the presence of the targeted fungus. To validate the developed system, 203 clinical samples suspected of fungal infection were collected from two hospitals in Kuala Lumpur and tested. Results: The limits of detection of the multiplexed PCR were in the range of 5–100 CFU/mL for fungal spiked human blood samples. Against the clinical diagnosis of proven or probable IFDs, the findings show that the LFA system produced a high specificity of 99.4 % while the sensitivity was only moderate at 47.8 % due to the difficulty of extracting fungal DNA from blood samples. The positive and negative predictive values however were promising at 91.7 % and 93.7 %, respectively. Conclusion: The developed LFA system has great potential for further refinement to be used as a new tool in the detection of IFDs. © 2025 The Authors
publisher Elsevier Ltd
issn 24058440
language English
format Article
accesstype All Open Access; Gold Open Access
record_format scopus
collection Scopus
_version_ 1825722572448202752